Guidance on an additional dose of COVID-19 vaccines in the spring of 2024 for individuals at high risk of severe illness due to COVID-19. : HP5-176/1-2024E-PDF ; HP5-176/2-2024E-PDF
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.931311&sl=1
| Ministère/Organisme | Public Health Agency of Canada, issuing body. Canada. National Advisory Committee on Immunization, issuing body. |
|---|---|
| Titre | Guidance on an additional dose of COVID-19 vaccines in the spring of 2024 for individuals at high risk of severe illness due to COVID-19. |
| Type de publication | Monographie |
| Langue | [Anglais] |
| Autres langues publiées | [Français] |
| Format | Électronique |
| Document électronique |
|
| Note(s) | Cover title. Issued also in French under title: Directives sur l'administration d'une dose supplémentaire de vaccins contre la COVID-19 au printemps 2024 pour les personnes exposées à un risque élevé de maladie sévère en raison de la COVID-19. At head of title: "An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)." Includes bibliographical references. |
| Information sur la publication | Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, January 12, 2024. ©2023 |
| Description | 1 online resource (13 unnumbered pages) + 1 summary (5 pages) |
| ISBN | 9780660692654 9780660692661 |
| Numéro de catalogue |
|
| Numéro de catalogue du ministère | 230641 (Guidance) 230643 (Summary) |
| Descripteurs | COVID-19 (Disease) -- Vaccination -- Government policy -- Canada. COVID-19 vaccines -- Government policy -- Canada. |